Search

Author/Creator Lowenfeld, Lea

1. Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer. (2nd September 2017)

Authors:
Lowenfeld, Lea; Zaheer, Salman; Oechsle, Crystal; Fracol, Megan; Datta, Jashodeep; Xu, Shuwen; Fitzpatrick, Elizabeth; Roses, Robert E.; Fisher, Carla S.; McDonald, Elizabeth S.; Zhang, Paul J.; DeMichele, Angela; Mick, Rosemarie; Koski, Gary K.; Czerniecki, Brian J.
Journal:
Oncoimmunology
Issue:
Volume 6:Number 9(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer. Issue 1 (December 2015)

Authors:
Datta, Jashodeep; Berk, Erik; Xu, Shuwen; Fitzpatrick, Elizabeth; Rosemblit, Cinthia; Lowenfeld, Lea; Goodman, Noah; Lewis, David; Zhang, Paul; Fisher, Carla; Roses, Robert; DeMichele, Angela; Czerniecki, Brian
Journal:
Breast cancer research
Issue:
Volume 17:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗